- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: RTA 744
Total 2798 results
-
M.D. Anderson Cancer CenterReata Pharmaceuticals, Inc.TerminatedLymphoma | Leukemia | Solid Tumor | Brain Tumor | Neoplastic MeningitisUnited States
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenTerminatedBrain MetastasesUnited States
-
Reata, a wholly owned subsidiary of BiogenTerminatedLeptomeningeal CarcinomatosisUnited States
-
AbbVieTerminatedAcute Myeloid Leukemia (AML)United States
-
Kyowa Kirin Co., Ltd.TerminatedType 2 Diabetes | Chronic Kidney DiseaseJapan
-
M.D. Anderson Cancer CenterReata Pharmaceuticals, Inc.CompletedSolid Tumors | Lymphoid MalignanciesUnited States
-
University of TorontoUniversity Health Network, TorontoTerminated
-
Reata, a wholly owned subsidiary of BiogenAbbVie; Friedreich's Ataxia Research AllianceActive, not recruitingFriedreich AtaxiaUnited States, Australia, Austria, Italy, United Kingdom
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompletedMItochondrial MyopathiesUnited States, Denmark
-
Reata, a wholly owned subsidiary of BiogenTerminatedChronic Kidney Diseases | Autosomal Dominant Polycystic Kidney | Alport SyndromeUnited States, France, Australia, Japan, Spain, Puerto Rico
-
Reata, a wholly owned subsidiary of BiogenCompletedDiabetic NephropathyUnited States
-
Reata, a wholly owned subsidiary of BiogenWithdrawn
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Kyowa Kirin Co., Ltd.TerminatedDiabetic Kidney DiseaseJapan
-
Reata, a wholly owned subsidiary of BiogenTerminatedLiver DiseaseUnited States
-
Kyowa Kirin Co., Ltd.TerminatedType 2 Diabetes | Chronic Kidney DiseaseJapan
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Kyowa Kirin Co., Ltd.CompletedType 2 Diabetes | Chronic Kidney DiseaseJapan
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingBladder Cancer | Non-Muscle-Invasive Urothelial CarcinomaUnited States
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompleted
-
King Fahad Specialist Hospital DammamUnknown
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Hamlet Pharma ABRecruitingNon-muscle Invasive Bladder CancerCzechia
-
Reata, a wholly owned subsidiary of BiogenNo longer available
-
University of HelsinkiHelsinki University Central Hospital; Olympus Surgical Technologies Europe,...Completed
-
Reata, a wholly owned subsidiary of BiogenRecruitingA Phase 2 Study of RTA 901 in Patients With Diabetic Peripheral Neuropathic Pain (CYPRESS) (CYPRESS)Diabetic Peripheral Neuropathic PainUnited States
-
U.S. Army Medical Research and Development CommandUS Army Medical Research Institute of Infectious DiseasesCompleted
-
ANRS, Emerging Infectious DiseasesEPISTEMCompleted
-
Medtronic EndovascularActive, not recruitingVenous RefluxUnited States, Korea, Republic of, France, Australia, United Kingdom, Canada, Germany, Netherlands, Spain, Italy
-
Southwest Hospital, ChinaUnknownHepatocellular CarcinomaChina
-
BiogenNot yet recruiting
-
Reata, a wholly owned subsidiary of BiogenTerminatedPulmonary HypertensionUnited States, Spain, Australia, United Kingdom, Canada, Belgium, Argentina, Israel, Japan, Philippines, Germany, Mexico, Brazil, Czechia, Netherlands
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompletedMetastatic or Incurable Non-small Cell Lung Cancer | Relapsed, Refractory MelanomaUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedAdvanced Solid Tumors | Lymphoid MalignanciesUnited States
-
Kyowa Kirin Co., Ltd.Completed
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompletedInflammation and Pain Following Ocular SurgeryUnited States
-
Kymera Therapeutics, Inc.CompletedAtopic Dermatitis | Healthy Volunteer | Hidradenitis SuppurativaUnited States
-
Corvus Pharmaceuticals, Inc.Completed
-
AbbVieActive, not recruitingMyelofibrosis (MF)United States, Argentina, Australia, Brazil, Bulgaria, Chile, Hungary, Israel, Italy, Japan, Korea, Republic of, Spain, Sweden, Turkey
-
U.S. Army Medical Research and Development CommandUS Army Medical Research Institute of Infectious DiseasesWithdrawnRicin PoisoningUnited States
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompletedOcular Inflammation | Ocular Pain | Corneal Endothelial Cell Loss | Cataract SurgeryUnited States
-
Komagome HospitalJapan Agency for Medical Research and Development; Prism Pharma Co., Ltd.CompletedHepatitis C Virus-infected CirrhosisJapan
-
Revance Therapeutics, Inc.Active, not recruiting
-
Alios Biopharma Inc.Completed
-
Reata, a wholly owned subsidiary of BiogenCompletedDiabetic Nephropathy | Type 2 Diabetes | Chronic Kidney DiseaseUnited States
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenCompletedHepatic ImpairmentUnited States